Biopharmaceutics Scientist/ Drug Product Design Biomodeler
Pfizer
Bart (Pharm.D, Ph.D) joined Pfizer Drug Product Design in November 2020 as a biopharmaceutics modeller teaming up with the global biopharmaceutics group. Prior to joining Pfizer, Bart had spent 4 years as a post-doc researcher on an FDA sponsored collaboration between University of Michigan (with Prof. Gordon Amidon) and KU Leuven (Belgium). His expertise is in the field of in vivo intubation studies in humans, biopredictive dissolution testing and PBPK modeling. Since joining Pfizer, he has used his knowledge of multiple modeling software platforms (including Gastroplus & DDDPlus and Simcyp & SIVA toolkit) to support a wide range of projects.
Disclosure information not submitted.
Hot Topic: Trends in Utility of Animal Studies in Oral Drug Development
Wednesday, October 23, 2024
3:00 PM – 4:00 PM MT